GE HealthCare Technologies (GEHC) 10-K Summary — Year Ended Dec 31, 2023
The filing covers risk factors, financial results, and internal control compliance for GE HealthCare Technologies Inc. No detailed business description is provided in the supplied sections.
Key takeaway
Year ended Dec 31, 2023 · FY2025 10-K
The filing covers risk factors, financial results, and internal control compliance for GE HealthCare Technologies Inc. No detailed business description is provided in the supplied sections.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$19.6B
Revenue reported for the fiscal year.
Operating income
$2.4B
Income from operations reported for the year.
Net income
$1.6B
Net income reported for the year.
Operating cash flow
n/a
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2021 | $17.6B | n/a |
| Dec 31, 2022 | $18.3B | +4.3% |
| Dec 31, 2023 | $19.6B | +6.6% |
Business overview
The supplied filing sections do not contain a detailed description of the company's business. The company is GE HealthCare Technologies Inc., a healthcare technology firm, and the filing covers risk factors, financial results, and internal control compliance.
Financial performance
Revenue increased compared to the prior year. The company reported operating income and net income for the period.
Material risks
The filing identifies risks related to internal control over financial reporting, including the possibility of fraud or misstatements. It also notes potential conflicts of interest due to directors and officers owning equity in both the company and GE.
Liquidity and capital
The supplied context does not provide information on liquidity or capital allocation.
What to watch
Readers should monitor the company's progress in maintaining effective internal controls over financial reporting.